A UCLA study published in December 2014 examined the use of selective serotonin reuptake inhibitors, or SSRIs, during pregnancy. The researchers used lab mice to observe the effects of SSRI exposure in the womb, and how it impacts adult mice.
They observed that adult mice exposed to the SSRI, Lexapro, experienced a permanent change in serotonin transmission, whereas those adult mice exposed to Prozac in the womb, showed no signs of this permanent change.
The UCLA study examined a new side of SSRIs and pregnancy, one documenting the longterm implications of SSRI exposure in the womb, rather than the immediate.
The immediate implications of SSRI exposure in the womb, to a certain degree, are already known. Children have been born with life-changing congenital birth defects. These birth defects include atrial septal defects, ventricular septal defects, Omphalocele, Craniosynostosis, and persistent pulmonary hypertension of the newborn (PPHN).
Carey Danis & Lowe Can Help
Carey Danis & Lowe is a national law firm with a strong reputation for expertly assisting families through the challenges of recovering losses after a child has been born with SSRI birth defects. Our defective drug lawyers understand the pain and suffering these children and their families endure, and are available to help.
Explore your legal options and compensation eligibility today during a free, no-obligation case evaluation.
Contact Carey Danis & Lowe by phone at 800.721.2519, or submit a confidential personal injury claim form.
We look forward to offering you and your family any assistance that we can.References: Lexapro, Paxil, Pharmaceutical litigation, Prozac, Zoloft